Anti IL-6R
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase III Trial of VDJ001 In Patients With Moderate-to-severe Active Rheumatoid Arthritis (NCT06726096) | Beijing VDJBio Co., LTD. | 2025-04-09 |
Track Anti IL-6R automatically
Every clearance here is in the API, with alerts when new ones post.